Skip to main content
PMC home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1983 Jan;23(1):133–137. doi: 10.1128/aac.23.1.133

Effect of furosemide on aminoglycoside-induced nephrotoxicity and auditory toxicity in humans.

C R Smith, P S Lietman
PMCID: PMC184630  PMID: 6830203

Abstract

We analyzed data from three prospective, controlled, randomized, double-blind clinical trails to determine whether furosemide increases the nephrotoxicity and auditory toxicity of aminoglycosides. All patients who received at least 72 h of treatment and who had no other cause for nephrotoxicity or auditory toxicity were included in the analysis. Nephrotoxicity developed in 10 of 50 (20.0%) patients given furosemide and in 38 of 222 (17.1%) patients not given furosemide (P greater than 0.3). Auditory toxicity developed in 5 of 23 patients (21.7%) given furosemide and in 28 of 119 patients (23.5%) not given furosemide (P greater than 0.3). In each case, the groups receiving and not receiving furosemide did not differ in mean age, initial creatinine, duration of aminoglycoside therapy, mean change in auditory acuity or creatinine, mean number of days to the development of toxicity, the frequency with which gentamicin, tobramycin, amikacin, or cephalothin was administered, or the mean predose and 1-h postdose plasma aminoglycoside levels. We conclude that furosemide use should not be considered a major risk factor for the development of aminoglycoside-induced nephrotoxicity or auditory toxicity.

Full text

PDF
133

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adelman R. D., Spangler W. L., Beasom F., Ishizaki G., Conzelman G. M. Furosemide enhancement of experimental gentamicin nephrotoxicity: comparison of functional and morphological changes with activities of urinary enzymes. J Infect Dis. 1979 Sep;140(3):342–352. doi: 10.1093/infdis/140.3.342. [DOI] [PubMed] [Google Scholar]
  2. Bennett W. M., Hartnett M. N., Gilbert D., Houghton D., Porter G. A. Effect of sodium intake on gentamicin nephrotoxicity in the rat. Proc Soc Exp Biol Med. 1976 Apr;151(4):736–738. doi: 10.3181/00379727-151-39296. [DOI] [PubMed] [Google Scholar]
  3. Brown R. D. Comparison of the cochlear toxicity of sodium ethacrynate, furosemide, and the cysteine adduct of sodium ethacrynate in cats. Toxicol Appl Pharmacol. 1975 Feb;31(2):270–282. doi: 10.1016/0041-008x(75)90162-3. [DOI] [PubMed] [Google Scholar]
  4. Brummett R. E., Traynor J., Brown R., Himes D. Cochlear damage resulting from kanamycin and furosemide. Acta Otolaryngol. 1975 Jul-Aug;80(1-2):86–92. doi: 10.3109/00016487509121305. [DOI] [PubMed] [Google Scholar]
  5. Bygbjerg I. C., Moller R. Gentamicin-induced nephropathy. Scand J Infect Dis. 1976;8(3):203–208. doi: 10.3109/inf.1976.8.issue-3.16. [DOI] [PubMed] [Google Scholar]
  6. Chan R. A., Benner E. J., Hoeprich P. D. Gentamicin therapy in renal failure: a nomogram for dosage. Ann Intern Med. 1972 May;76(5):773–778. doi: 10.7326/0003-4819-76-5-773. [DOI] [PubMed] [Google Scholar]
  7. Chiu P. J., Long J. F. Effects of hydration on gentamicin excretion and renal accumulation in furosemide-treated rats. Antimicrob Agents Chemother. 1978 Aug;14(2):214–217. doi: 10.1128/aac.14.2.214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gallagher K. L., Jones J. K. Furosemide-induced ototoxicity. Ann Intern Med. 1979 Nov;91(5):744–745. doi: 10.7326/0003-4819-91-5-744. [DOI] [PubMed] [Google Scholar]
  9. Johnson A. H., Hamilton C. H. Kanamycin ototoxicity--possible potentiation by other drugs. South Med J. 1970 May;63(5):511–513. doi: 10.1097/00007611-197005000-00007. [DOI] [PubMed] [Google Scholar]
  10. Lawson D. H., Macadam R. F., Singh M. H., Gavras H., Hartz S., Turnbull D., Linton A. L. Effect of furosemide on antibiotic-induced renal damage in rats. J Infect Dis. 1972 Dec;126(6):593–600. doi: 10.1093/infdis/126.6.593. [DOI] [PubMed] [Google Scholar]
  11. Mathog R. H., Klein W. J., Jr Ototoxicity of ethacrynic acid and aminoglycoside antibiotics in uremia. N Engl J Med. 1969 May 29;280(22):1223–1224. doi: 10.1056/NEJM196905292802208. [DOI] [PubMed] [Google Scholar]
  12. Meriwether W. D., Mangi R. J., Serpick A. A. Deafness following standard intravenous dose of ethacrynic acid. JAMA. 1971 May 3;216(5):795–798. [PubMed] [Google Scholar]
  13. Nakai Y. Combined effect of 3', 4'-dideoxykanamycin B and potent diuretics on the cochlea. (A scanning and transmission electron microscopic evaluation). Laryngoscope. 1977 Sep;87(9 Pt 1):1548–1558. doi: 10.1288/00005537-197709000-00015. [DOI] [PubMed] [Google Scholar]
  14. Noël P., Levy V. G. Toxicité rénale de l'association gentamicine-furosémide. Une observation. Nouv Presse Med. 1978 Feb 4;7(5):351–353. [PubMed] [Google Scholar]
  15. Ohtani I., Ohtsuki K., Omata T., Ouchi J., Saito T. Potentiation and its mechanism of cochlear damage resulting from furosemide and aminoglycoside antibiotics. ORL J Otorhinolaryngol Relat Spec. 1978;40(1):53–63. doi: 10.1159/000275386. [DOI] [PubMed] [Google Scholar]
  16. Prazma J., Browder J. P., Fischer N. D. Ethacrynic acid ototoxicity potentiation by kanamycin. Ann Otol Rhinol Laryngol. 1974 Jan-Feb;83(1):111–118. doi: 10.1177/000348947408300118. [DOI] [PubMed] [Google Scholar]
  17. Prince R. A., Ling M. H., Hepler C. D., Rainville E. C., Kealey G. P., Donta S. T., LeFrock J. L., Kowalsky S. F. Factors associated with creatinine clearance changes following gentamicin therapy. Am J Hosp Pharm. 1980 Nov;37(11):1489–1495. [PubMed] [Google Scholar]
  18. Smith C. R., Baughman K. L., Edwards C. Q., Rogers J. F., Lietman P. S. Controlled comparison of amikacin and gentamicin. N Engl J Med. 1977 Feb 17;296(7):349–353. doi: 10.1056/NEJM197702172960701. [DOI] [PubMed] [Google Scholar]
  19. Smith C. R., Lipsky J. J., Laskin O. L., Hellmann D. B., Mellits E. D., Longstreth J., Lietman P. S. Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin. N Engl J Med. 1980 May 15;302(20):1106–1109. doi: 10.1056/NEJM198005153022002. [DOI] [PubMed] [Google Scholar]
  20. Smith C. R., Maxwell R. R., Edwards C. Q., Rogers J. F., Lietman P. S. Nephrotoxicity induced by gentamicin and amikacin. Johns Hopkins Med J. 1978 Mar;142(3):85–90. [PubMed] [Google Scholar]
  21. Wade J. C., Smith C. R., Petty B. G., Lipsky J. J., Conrad G., Ellner J., Lietman P. S. Cephalothin plus an aminoglycoside is more nephrotoxic than methicillin plus an aminoglycoside. Lancet. 1978 Sep 16;2(8090):604–606. doi: 10.1016/s0140-6736(78)92825-8. [DOI] [PubMed] [Google Scholar]
  22. West B. A., Brummett R. E., Himes D. L. Interaction of kanamycin and ethacrynic acid. Severe cochlear damage in guinea pigs. Arch Otolaryngol. 1973 Jul;98(1):32–37. doi: 10.1001/archotol.1973.00780020036009. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES